Avaleht/Aktsiad/CGC

CGC

USD

Canopy Growth Corporation Common Shares

$1.130-0.040 (-3.419%)

Reaalajas hind

Healthcare

Drug Manufacturers - Specialty & Generic

Kanada

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad

Ettevõtte fundamentaalnäitajad

Kauplemisstatistika

Turunäitajad

Avatud

$1.170

Kõrge

$1.180

Madal

$1.100

Maht

16.14M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

384.7M

Tööstusharu

Drug Manufacturers - Specialty & Generic

Riik

Canada

Kauplemisstatistika

Keskmine maht

25.81M

Börs

NMS

Valuuta

USD

52 nädala vahemik

Madal $0.77Praegune $1.130Kõrge $5.61

Seotud uudised

10. nov 2025 · 12:41

Analyst Upgrades

Benchmark Upgrades Canopy Growth to Hold

Benchmark analyst Mike Hickey upgrades Canopy Growth from Sell to Hold.

Vaata rohkem

Benchmark Upgrades Canopy Growth to Hold

1. nov 2025 · 12:00

CNBC

'Trump effect' raises hopes for cannabis rally as investors bet on federal reforms, softer marijuana stance

Cannabis stocks could rally on hopes for new hemp regulations and Trump's possible softer stance on marijuana, fueling investor optimism across the industry.

Vaata rohkem

'Trump effect' raises hopes for cannabis rally as investors bet on federal reforms, softer marijuana stance

24. okt 2025 · 11:00

BusinessWire

Canopy Growth to Report Second Quarter Fiscal 2026 Financial Results on November 7, 2025

Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED, NASDAQ:CGC) will release its financial results for the second quarter fiscal year 2026 ended September 30, 2025 before financial markets open on

Vaata rohkem